Critically, we identified UBE2S, a ubiquitin-conjugating enzyme upregulated in tumor-infiltrating NK (TiNK) cells from NSCLC patients and our in vitro models, as a likely mediator of this process. The gene discussed is UBE2S; the disease is non-small cell lung carcinoma.